Headshot of Bryan Howcroft, Chief Executive Officer, Director for Medipharm Labs

Bryan Howcroft

Chief Executive Officer, Director

Bryan Howcroft brings over 20 years of leadership in multiple industries including medical devices, healthcare imaging, and manufacturing. Most recently, Bryan held the position of Chief Operational Officer and Chief Financial Officer of Southmedic, a company that provides healthcare products, custom manufacturing, and distribution in over 60 countries globally. Bryan's previous experience makes him the ideal executive appointment in the international cannabis industry as the healthcare sector, like cannabis, is heavily regulated and requires expertise in navigating complex global regulatory regimes, including the US FDA, and country-specific medical distribution regulations. Bryan’s tenure at Southmedic included an extremely significant scaling of the business to a multisite operation. Southmedic is recognized as one of Canada's largest privately held medical device companies.

Bryan also has significant European experience as a healthcare IT executive in Belgium for over four years. In 2021, MediPharm Labs’ main growth area has been in the European markets and under the leadership of Bryan Howcroft, the Company expects to accelerate the business opportunities in that region.

Headshot of Keith Strachan, President for Medipharm Labs

Keith Strachan


Keith Strachan co-founded MediPharm Labs in 2015, utilizing his consultancy expertise in Public Sector RFP and government contracts, compliance for government licensing and local planning, to break the mold and secure the first Health Canada Licence for cannabis oil production without first being a cultivator. A seasoned entrepreneur, Keith has applied his leadership to building out MediPharm Labs’ leading-edge facilities, launching operations and growing its workforce, while also strategically driving business development with the Company’s many supply, contract processing and white label partner LPs.

Headshot of Ahmed Shehata, General Counsel and Head of Corporate Development for Medipharm Labs

Ahmed Shehata

General Counsel and Head of Corporate Development

Ahmed comes to MediPharm after having spent over a decade working in the Bay Street offices of the Business Law Group of one of the world's largest law firms and in the Corporate Law Group of a global leader in Canadian business law. His legal practice consisted of securities law, mergers & acquisitions, corporate finance and general corporate and commercial law. Ahmed has acted as external counsel for numerous cannabis companies and has been involved in a legal advisory role in the going public transactions of cannabis companies as well as companies in several other industries. He holds a Juris Doctor Law Degree from Osgoode Hall Law School and a Bachelor of Commerce Honours Degree with First Class Honours from the Queen's University School of Business.

Headshot of Kirk Binns, Executive Vice President, Global Accounts for Medipharm Labs

Kirk Binns

Executive Vice President, Global Accounts

A Molecular Biologist by training, Kirk Binns was a founding shareholder of MediPharm Labs. A serial entrepreneur, Kirk has spent most of his career in the North American deregulated energy markets, leading market expansions, client acquisitions and managed up to 100 reports across multiple markets. Over the last 12 years, he established and ran a multinational energy sales organization generating 7-figures annually, while also contributing to MediPharm Labs’ start-up and operations. Kirk takes on the role of EVP, Global Accounts to help MediPharm Labs realize its vision as the trusted global leader in cannabinoid-based derivatives.

Headshot of Greg Hunter, Chief Financial Officer for Medipharm Labs

Greg Hunter

Chief Financial Officer

Greg Hunter brings over 20 years of experience as a business executive holding various senior finance and leadership roles across multiple industries including healthcare distribution, telecommunications, pharmaceuticals, biotechnology, medical device and consumer packaged goods. Greg also brings a track record and deep expertise in capital management, audit, compliance, tax, treasury, ERP, manufacturing, contract management and pricing strategy.

Most recently, Greg was Chief Financial Officer of Medical Pharmacies Group Limited, a leading pharmacy and medical equipment manufacturer and distributor in Canada. Previously in the pharmaceuticals industry, Greg held various senior management roles with Baxter International Inc. including serving as CFO of Baxter’s Canadian subsidiary. Greg also previously held various senior operational and finance roles at Janssen-Ortho Inc., a Johnson and Johnson company.

Greg holds an MBA from McMaster University, an Honors B.Sc. in Microbiology and Immunology from University of Western Ontario and is a Chartered Professional Accountant.

Headshot of Brett Moon, Vice President, Sales for Medipharm Labs

Brett Moon

Vice President, Sales

Brett joins MediPharm Labs with over a decade of sales, marketing and CPG experience. Previously Brett was Vice President at Mosaic Sales Solutions – Canada’s largest sales and marketing agency. At Mosaic, Brett led accounts such as Anheuser Busch InBev, Nike, and Nestle. Recently Brett has led sales in the cannabis industry, working and consulting for some of the largest LPs in Canada. As VP of Sales at MediPharm Labs, Brett will be accountable for maximizing the sales and distribution of MediPharm’s best-in-class vape, and other innovative cannabis products.

Headshot of Dr. Chris Talpas, Vice President, Technical and Scientific Affairs for Medipharm Labs

Dr. Chris Talpas

Vice President, Technical and Scientific Affairs

Chris has 24 years of experience in the bio-pharmaceutical field, having been involved in all aspects of development from bench-top to commercial manufacture. After completing his BSc. and Doctorate degrees in Biochemistry, he joined Hemosol as a research scientist and then transitioned into the Process Development group where he worked on scaling up the manufacturing process to support clinical manufacturing of a haemoglobin-based blood substitute. Thereafter, he managed the clinical manufacturing plant. An expert in Chromatography, Dr. Talpas comes to MediPharm with a wealth of expertise in the qualification and validation of complex processes and equipment, as well as the development and maintenance of quality systems, having just served as the Director of Manufacturing Sciences at Therapure Biopharma. 

Headshot of Geoff Marr, Vice President, Associate General Counsel  for Medipharm Labs

Geoff Marr

Vice President, Associate General Counsel

Geoff brings over a decade of legal experience at top Canadian brands and on Bay Street. Most recently he held a senior position at Canada Goose, where he was a strategic legal and business advisor for the company’s first retail store openings, e-commerce expansion, supply chain initiatives, and its launch into China and Hong Kong. He also supported the business through its IPO process on the TSX and NYSE. Geoff has a strong background in marketing and intellectual property law, and ran Canada Goose’s global IP and brand protection programs. Prior to Canada Goose, Geoff was in-house counsel for Tim Hortons, and a corporate lawyer in private practice, working in venture capital and M&A.

Headshot of Saravan Subramaniam, Vice President, Operations and Supply Chain for Medipharm Labs

Saravan Subramaniam

Vice President, Operations and Supply Chain

Saravan has worked in the Pharmaceutical Industry for over 12 years in roles focusing on Engineering and Technical Services. He has led projects which included new product launches in both Manufacturing and Commercial environments, and the design of a $30M High Containment Facility for the manufacturing of Soft Gel Capsules. Previously, he was a Project Manager in the Automotive Sector. Saravan is an authentic leader of successful teams by modelling a collaborative and hands on approach, providing opportunities for shared leadership, communicating effectively and motivating teams towards shared goals. Saravan obtained his bachelor’s degree in Electrical Engineering at the University of Waterloo, and recently completed his Executive MBA at the Rotman School of Management, University of Toronto.

Headshot of Nigel Dewsbury, VP, Quality and Regulatory Affairs for Medipharm Labs

Nigel Dewsbury

VP, Quality and Regulatory Affairs

A Certified Pharmaceutical GMP Professional (CPGP) with over 18 years of experience in the pharmaceutical and medical device industry, Nigel Dewsbury brings considerable expertise in quality systems and management to the MediPharm Labs team. Prior to joining MediPharm Labs, Nigel held senior quality assurance roles with a variety of organizations, including Baxter Healthcare, Derma Sciences Inc. and Nuvo Research Inc. He boasts a successful record of hosting regulatory authorities, including Health Canada and the U.S. Food and Drug Administration, as well as working with third-party auditors and ISO registrars. Nigel holds a Bachelor of Science degree in Chemistry from the University of Western Ontario and a Certified Six Sigma Green Belt designation from McGill University.